> top > projects > sentences > docs > PubMed:19389916 > annotations
sentences Home  

PubMed:19389916 JSONTXT 55 Projects

Annnotations TAB TSV DIC JSON TextAE

Id Subject Object Predicate Lexical cue
TextSentencer_T1 0-168 Sentence denotes Xylosyltransferase II is a significant contributor of circulating xylosyltransferase levels and platelets constitute an important source of xylosyltransferase in serum.
T1 0-168 Sentence denotes Xylosyltransferase II is a significant contributor of circulating xylosyltransferase levels and platelets constitute an important source of xylosyltransferase in serum.
T1 0-168 Sentence denotes Xylosyltransferase II is a significant contributor of circulating xylosyltransferase levels and platelets constitute an important source of xylosyltransferase in serum.
TextSentencer_T2 169-309 Sentence denotes Circulating glycosyltransferases including xylosyltransferases I (XylT1) and II (XylT2) are potential serum biomarkers for various diseases.
T2 169-309 Sentence denotes Circulating glycosyltransferases including xylosyltransferases I (XylT1) and II (XylT2) are potential serum biomarkers for various diseases.
T2 169-309 Sentence denotes Circulating glycosyltransferases including xylosyltransferases I (XylT1) and II (XylT2) are potential serum biomarkers for various diseases.
TextSentencer_T3 310-511 Sentence denotes Understanding what influences the serum activity of these enzymes as well as the sources of these enzymes is important to interpreting the significance of alterations in enzyme activity during disease.
T3 310-511 Sentence denotes Understanding what influences the serum activity of these enzymes as well as the sources of these enzymes is important to interpreting the significance of alterations in enzyme activity during disease.
T3 310-511 Sentence denotes Understanding what influences the serum activity of these enzymes as well as the sources of these enzymes is important to interpreting the significance of alterations in enzyme activity during disease.
TextSentencer_T4 512-605 Sentence denotes This article demonstrates that in the mouse and human the predominant XylT in serum is XylT2.
T4 512-605 Sentence denotes This article demonstrates that in the mouse and human the predominant XylT in serum is XylT2.
T4 512-605 Sentence denotes This article demonstrates that in the mouse and human the predominant XylT in serum is XylT2.
TextSentencer_T5 606-781 Sentence denotes Furthermore, that total XylT levels in human serum are approximately 200% higher than those in plasma due in part to XylT released by platelets during blood clotting in vitro.
T5 606-781 Sentence denotes Furthermore, that total XylT levels in human serum are approximately 200% higher than those in plasma due in part to XylT released by platelets during blood clotting in vitro.
T5 606-781 Sentence denotes Furthermore, that total XylT levels in human serum are approximately 200% higher than those in plasma due in part to XylT released by platelets during blood clotting in vitro.
TextSentencer_T6 782-924 Sentence denotes In addition, the data from Xylt2 knock-out mice and mice with liver neoplasia show that liver is a significant source of serum XylT2 activity.
T6 782-924 Sentence denotes In addition, the data from Xylt2 knock-out mice and mice with liver neoplasia show that liver is a significant source of serum XylT2 activity.
T6 782-924 Sentence denotes In addition, the data from Xylt2 knock-out mice and mice with liver neoplasia show that liver is a significant source of serum XylT2 activity.
TextSentencer_T7 925-1088 Sentence denotes The data presented suggest that serum XylT levels may be an informative biomarker in patients who suffer from diseases affecting platelet and/or liver homeostasis.
T7 925-1088 Sentence denotes The data presented suggest that serum XylT levels may be an informative biomarker in patients who suffer from diseases affecting platelet and/or liver homeostasis.
T7 925-1088 Sentence denotes The data presented suggest that serum XylT levels may be an informative biomarker in patients who suffer from diseases affecting platelet and/or liver homeostasis.